TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

CUSIP: 89455T109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common stock, $0.001 par value
Shares outstanding
63,703,704
Total 13F shares
17,228,093
Share change
+4,107,446
Total reported value
$320,930,460
Price per share
$18.64
Number of holders
74
Value change
+$66,992,636
Number of buys
55
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 89455T109?
CUSIP 89455T109 identifies TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q4 2021

As of 31 Dec 2021, TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,228,093 shares. The largest 10 holders included ALLIANCEBERNSTEIN L.P., VANGUARD GROUP INC, NEXT CENTURY GROWTH INVESTORS LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, JANUS HENDERSON GROUP PLC, FMR LLC, Novo Holdings A/S, and Raymond James Financial Services Advisors, Inc.. This page lists 74 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.